The distribution of IgG subclasses in the lupus band suggests disease-specific alteration in subclass switching rather than polyclonal B-cell activation

Clinical and Experimental Dermatology

Volumn 29, Issue 3, 2004, Pages 288-292

  Alahlafi, A M ^a   Wordsworth, P ^a   Wojnarowska, F ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN SUBCLASS;

ARTICLE; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUPUS ERYTHEMATOSUS; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SKIN BIOPSY; TISSUE DISTRIBUTION;

ALPHA-MACROGLOBULINS; B-LYMPHOCYTES; BASEMENT MEMBRANE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; SKIN;

EID: 2442709115     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01520.x     Document Type: Article

References (16)

1. Burnham TK, Neblett TR, Fine G. The application of the fluorescent antibody technique to the investigation of lupus erythematosus and various dermatoses. J Invest Dermatol 1963; 41: 451-6.
2. Cormane RH. Bound immunoglobulin in the skin of patients with chronic discoid lupus erythematosus and systemic lupus erythematosus. Lancet 1964; 1: 534-5.
3. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982; 25: 1271-7.
4. Harrist TJ, Mihm MC. The specificity and clinical usefulness of the lupus band test. Arthritis Rheum 1980; 23: 479-89.
5. Ahmed AR, Provost TT. Incidence of a positive LBT using sun-exposed and un-sun-exposed skin. Arch Dermatol 1979; 115: 228-9.
6. Provost T, Reichlin M. Immunopathologic studies of cutaneous lupus erythematosus. J Clin Immunol 1988; 8: 223-33.
7. Izui S, McConahey PJ, Dixon FJ. Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J Immunol 1978; 121: 2213-9.
8. Hagiwara E, Gourley M, Lee S, Klinman D. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon gamma secreting cells in the peripheral blood. Arthritis Rheum 1996; 39: 379-85.
9. Llorente L, Zou W, Levy Y et al. Role of IL-10 in B cell hyperactivity and autoantibody production of human SLE. J Exp Med 1995; 181: 839-44.
10. Saluk PH, Clem LW. The unique molecular weight of the heavy chain from human IgG3 proteins due to an extended hinge region. J Immunol 1971; 107: 298-302.
11. Michaelsen TE, Frangione B, Franklin C. Primary structure of the hinge region of human IgG3, Probable quadruplication of a 15-amino acid residue basic unit. J Biol Chem 1977; 252: 883-9.
12. Wu J, Bansal V, Redecha P et al. A novel polymorphism of FcãRIIIA, which alters function, associated with the SLE phenotype. J Invest Med 1997; 45: 200A.
13. Izui S, Berney T, Shibata T, Fulpius T. IgG3 cryoglobulins in autoimmune MRL-lpr/lpr mice: immunopathogenesis, therapeutic approaches and relevance to similar human diseases. Ann Rheum Dis 1993; 52: S48-S54.
14. Miwa T, Maladano M, Zhou L et al. Deletion of decay-accelarating factor (CD5 5) exacerbates autoimmune disease development in MRL/lpr mice. Am J Pathol 2002; 161: 1077-85.
15. Edwards J, Cambridge G, Abrahams V. Do self-perpetuating B lymphocytes drive human autoimmune diseases? Immunology 1999; 97: 188-96.
16. Bennion D, Ferris C, Lieu T et al. IgG subclasses in the serum and skin in subacute cutaneous lupus erythematosus and neonatal lupus erythematosus. J Invest Dermatol 1990; 95: 643-6.